{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:52:10Z","timestamp":1762145530141,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada.","doi-asserted-by":"crossref","award":["RGPIN-2016-05697"],"award-info":[{"award-number":["RGPIN-2016-05697"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11033-020-05482-8","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T04:09:50Z","timestamp":1589429390000},"page":"4867-4873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["5-Azacytidine upregulates melatonin MT1 receptor expression in rat C6 glioma cells: oncostatic implications"],"prefix":"10.1007","volume":"47","author":[{"given":"Emily E.","family":"Hartung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumeya Z.","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-1319","authenticated-orcid":false,"given":"Lennard P.","family":"Niles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"5482_CR1","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s00429-017-1439-6","volume":"222","author":"KY Ng","year":"2017","unstructured":"Ng KY, Leong MK, Liang H, Paxinos G (2017) Melatonin receptors: distribution in mammalian brain and their respective putative functions. Brain Struct Funct 222:2921\u20132939. https:\/\/doi.org\/10.1007\/s00429-017-1439-6","journal-title":"Brain Struct Funct"},{"key":"5482_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","volume":"56","author":"J Liu","year":"2015","unstructured":"Liu J, Clough SJ, Hutchinson AJ et al (2015) MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu Rev Pharmacol Toxicol 56:361\u2013383. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010814-124742","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5482_CR3","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/molecules23030530","volume":"23","author":"A Galano","year":"2018","unstructured":"Galano A, Tan DX, Reiter RJ (2018) Melatonin: a versatile protector against oxidative DNA damage. Molecules 23:530","journal-title":"Molecules"},{"key":"5482_CR4","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY et al (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734\u201336741. https:\/\/doi.org\/10.1074\/jbc.M101287200","journal-title":"J Biol Chem"},{"key":"5482_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1471-4159.2005.03457.x","volume":"95","author":"LM Castro","year":"2005","unstructured":"Castro LM, Gallant M, Niles LP (2005) Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J Neurochem 95:1227\u20131236. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03457.x","journal-title":"J Neurochem"},{"key":"5482_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejphar.2007.01.022","volume":"560","author":"S Jawed","year":"2007","unstructured":"Jawed S, Kim B, Ottenhof T et al (2007) Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. Eur J Pharmacol 560:17\u201322. https:\/\/doi.org\/10.1016\/j.ejphar.2007.01.022","journal-title":"Eur J Pharmacol"},{"key":"5482_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejphar.2008.04.058","volume":"589","author":"B Kim","year":"2008","unstructured":"Kim B, Rincon Castro LM, Jawed S, Niles LP (2008) Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. Eur J Pharmacol 589:45\u201348. https:\/\/doi.org\/10.1016\/j.ejphar.2008.04.058","journal-title":"Eur J Pharmacol"},{"key":"5482_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1017\/S1461145711001969","volume":"15","author":"LP Niles","year":"2012","unstructured":"Niles LP, Sathiyapalan A, Bahna S et al (2012) Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. Int J Neuropsychopharmacol 15:1343\u20131350. https:\/\/doi.org\/10.1017\/S1461145711001969","journal-title":"Int J Neuropsychopharmacol"},{"key":"5482_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2014.05.056","volume":"576C","author":"SG Bahna","year":"2014","unstructured":"Bahna SG, Sathiyapalan A, Foster JA, Niles LP (2014) Regional upregulation of hippocampal melatonin MT receptors by valproic acid: therapeutic implications for Alzheimer\u2019s disease. Neurosci Lett 576C:84\u201387. https:\/\/doi.org\/10.1016\/j.neulet.2014.05.056","journal-title":"Neurosci Lett"},{"key":"5482_CR10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.euroneuro.2017.06.002","volume":"27","author":"SG Bahna","year":"2017","unstructured":"Bahna SG, Niles LP (2017) Epigenetic induction of melatonin MT 1 receptors by valproate: neurotherapeutic implications. Eur Neuropsychopharmacol 27:828\u2013832. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.06.002","journal-title":"Eur Neuropsychopharmacol"},{"key":"5482_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G (2013) DNA methylation and its basic function. Neuropsychopharmacology 38:23\u201338","journal-title":"Neuropsychopharmacology"},{"key":"5482_CR12","first-page":"2723","volume":"31","author":"S Sarkar","year":"2011","unstructured":"Sarkar S, Abujamra AL, Loew JE et al (2011) Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res 31:2723\u20132732","journal-title":"Anticancer Res"},{"key":"5482_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/abr.abr_91_19","volume":"8","author":"M Sanaei","year":"2019","unstructured":"Sanaei M, Kavoosi F (2019) Effect of 5-aza-2\u2019-deoxycytidine in comparison to valproic acid and trichostatin a on histone deacetylase 1, dna methyltransferase 1, and cip\/kip family (p21, p27, and p57) genes expression, cell growth inhibition, and apoptosis induction in colon cancer sw480 cell line. Adv Biomed Res 8:52. https:\/\/doi.org\/10.4103\/abr.abr_91_19","journal-title":"Adv Biomed Res"},{"key":"5482_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/bjc.1987.187","volume":"56","author":"R Cortvrindt","year":"1987","unstructured":"Cortvrindt R, Bernheim J, Buyssens N, Roobol K (1987) 5-Azacytidine and 5-aza-2\u2019-deoxycytidine behave as different antineoplastic agents in B16 melanoma. Br J Cancer 56:261\u2013265. https:\/\/doi.org\/10.1038\/bjc.1987.187","journal-title":"Br J Cancer"},{"key":"5482_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.7150\/ijbs.4729","volume":"9","author":"A Montesano","year":"2013","unstructured":"Montesano A, Luzi L, Senesi P, Terruzzi I (2013) Modulation of cell cycle progression by 5-azacytidine is associated with early myogenesis induction in murine myoblasts. Int J Biol Sci 9:391\u2013402. https:\/\/doi.org\/10.7150\/ijbs.4729","journal-title":"Int J Biol Sci"},{"key":"5482_CR16","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1096\/fj.11-186122","volume":"25","author":"M Hupkes","year":"2011","unstructured":"Hupkes M, Jonsson MKB, Scheenen WJ et al (2011) Epigenetics: DNA demethylation promotes skeletal myotube maturation. FASEB J 25:3861\u20133872. https:\/\/doi.org\/10.1096\/fj.11-186122","journal-title":"FASEB J"},{"key":"5482_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.advenzreg.2006.01.011","volume":"46","author":"F Spada","year":"2006","unstructured":"Spada F, Rothbauer U, Zolghadr K et al (2006) Regulation of DNA methyltransferase 1. Adv Enzyme Regul 46:224\u2013234. https:\/\/doi.org\/10.1016\/j.advenzreg.2006.01.011","journal-title":"Adv Enzyme Regul"},{"key":"5482_CR18","first-page":"763","volume":"43","author":"JK Christman","year":"1983","unstructured":"Christman JK, Mendelsohn N, Herzog D, Schneiderman N (1983) Effect of 5-azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60). Cancer Res 43:763\u2013769","journal-title":"Cancer Res"},{"key":"5482_CR19","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3892\/ijo.2015.3110","volume":"47","author":"S-M Yu","year":"2015","unstructured":"Yu S-M, Kim S-J (2015) DNA-hypomethylating agent, 5\u2019-azacytidine, induces cyclooxygenase-2 expression via the PI3-kinase\/Akt and extracellular signal-regulated kinase-1\/2 pathways in human HT1080 fibrosarcoma cells. Int J Oncol 47:1469\u20131475. https:\/\/doi.org\/10.3892\/ijo.2015.3110","journal-title":"Int J Oncol"},{"key":"5482_CR20","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s11064-015-1601-6","volume":"40","author":"AL Green","year":"2015","unstructured":"Green AL, Hossain MM, Tee SC et al (2015) Epigenetic regulation of dopamine transporter mRNA expression in human neuroblastoma cells. Neurochem Res 40:1372\u20131378. https:\/\/doi.org\/10.1007\/s11064-015-1601-6","journal-title":"Neurochem Res"},{"key":"5482_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00001813-200503000-00009","volume":"16","author":"M Lemaire","year":"2005","unstructured":"Lemaire M, Momparler LF, Bernstein ML et al (2005) Enhancement of antineoplastic action of 5-aza-2\u2019-deoxycytidine by zebularine on L1210 leukemia. Anticancer Drugs 16:301\u2013308. https:\/\/doi.org\/10.1097\/00001813-200503000-00009","journal-title":"Anticancer Drugs"},{"key":"5482_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13:484\u2013492. https:\/\/doi.org\/10.1038\/nrg3230","journal-title":"Nat Rev Genet"},{"key":"5482_CR23","doi-asserted-by":"publisher","first-page":"e69964","DOI":"10.1371\/journal.pone.0069964","volume":"8","author":"JE Hanson","year":"2013","unstructured":"Hanson JE, La H, Plise E et al (2013) SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition. PLoS ONE 8:e69964. https:\/\/doi.org\/10.1371\/journal.pone.0069964","journal-title":"PLoS ONE"},{"key":"5482_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/1541-7786.MCR-07-0330","volume":"6","author":"Q Zhou","year":"2008","unstructured":"Zhou Q, Agoston AT, Atadja P et al (2008) Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol Cancer Res 6:873\u2013883. https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-0330","journal-title":"Mol Cancer Res"},{"key":"5482_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1874467210902010095","volume":"2","author":"B Monti","year":"2009","unstructured":"Monti B, Polazzi E, Contestabile A (2009) Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2:95\u2013109","journal-title":"Curr Mol Pharmacol"},{"key":"5482_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2006-12-060947","volume":"110","author":"AV Ougolkov","year":"2007","unstructured":"Ougolkov AV, Bone ND, Fernandez-Zapico ME et al (2007) Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood 110:735\u2013742. https:\/\/doi.org\/10.1182\/blood-2006-12-060947","journal-title":"Blood"},{"key":"5482_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar H, Bergman Y (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10:295\u2013304. https:\/\/doi.org\/10.1038\/nrg2540","journal-title":"Nat Rev Genet"},{"key":"5482_CR28","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3389\/fphar.2018.01086","volume":"9","author":"G Favero","year":"2018","unstructured":"Favero G, Moretti E, Bonomini F et al (2018) Promising antineoplastic actions of melatonin. Front Pharmacol 9:1086. https:\/\/doi.org\/10.3389\/fphar.2018.01086","journal-title":"Front Pharmacol"},{"key":"5482_CR29","doi-asserted-by":"publisher","first-page":"85655","DOI":"10.18632\/oncotarget.21107","volume":"8","author":"S-C Su","year":"2017","unstructured":"Su S-C, Ho Y-C, Liu Y-F et al (2017) Association of melatonin membrane receptor 1A\/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma. Oncotarget 8:85655\u201385669. https:\/\/doi.org\/10.18632\/oncotarget.21107","journal-title":"Oncotarget"},{"key":"5482_CR30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/cells8070745","volume":"8","author":"L Zhang","year":"2019","unstructured":"Zhang L, He Y, Wu X et al (2019) Melatonin and (-)-epigallocatechin-3-gallate: partners in fighting cancer. Cells 8:745. https:\/\/doi.org\/10.3390\/cells8070745","journal-title":"Cells"},{"key":"5482_CR31","doi-asserted-by":"publisher","first-page":"e12586","DOI":"10.1111\/jpi.12586","volume":"67","author":"S Xiang","year":"2019","unstructured":"Xiang S, Dauchy RT, Hoffman AE et al (2019) Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer. J Pineal Res 67:e12586. https:\/\/doi.org\/10.1111\/jpi.12586","journal-title":"J Pineal Res"},{"key":"5482_CR32","doi-asserted-by":"publisher","first-page":"39896","DOI":"10.18632\/oncotarget.16379","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Li S, Zhou Y et al (2017) Melatonin for the prevention and treatment of cancer. Oncotarget 8:39896\u201339921. https:\/\/doi.org\/10.18632\/oncotarget.16379","journal-title":"Oncotarget"},{"key":"5482_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10549-012-2371-3","volume":"137","author":"G Oprea-Ilies","year":"2013","unstructured":"Oprea-Ilies G, Haus E, Sackett-Lundeen L et al (2013) Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival. Breast Cancer Res Treat 137:677\u2013687. https:\/\/doi.org\/10.1007\/s10549-012-2371-3","journal-title":"Breast Cancer Res Treat"},{"key":"5482_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1874467212666190313154531","volume":"12","author":"S Abou Najem","year":"2019","unstructured":"Abou Najem S, Khawaja G, Hodroj MH, Rizk S (2019) Synergistic Effect of epigenetic inhibitors decitabine and suberoylanilide hydroxamic acid on colorectal cancer in vitro. Curr Mol Pharmacol 12:281\u2013300. https:\/\/doi.org\/10.2174\/1874467212666190313154531","journal-title":"Curr Mol Pharmacol"},{"key":"5482_CR35","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1111\/bph.14058","volume":"175","author":"SG Bahna","year":"2018","unstructured":"Bahna SG, Niles LP (2018) Epigenetic regulation of melatonin receptors in neuropsychiatric disorders. Br J Pharmacol 175:3209\u20133219","journal-title":"Br J Pharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05482-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:33:54Z","timestamp":1620952434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05482-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["5482"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05482-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2020,5,14]]},"assertion":[{"value":"24 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}